DRD5 anticorps (C-Term)
-
- Antigène Voir toutes DRD5 Anticorps
- DRD5 (Dopamine Receptor D5 (DRD5))
-
Épitope
- C-Term
-
Reactivité
- Rat
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp DRD5 est non-conjugé
-
Application
- Western Blotting (WB)
- Specificité
- Reacts with rat D(1B) dopamine receptor
- Réactivité croisée (Details)
- Do not react with human protein. Not tested in other species.
- Purification
- Purified (protein A)
- Immunogène
- Recombinant rat D1 (D1B) dopamine receptor (within the last 118 of the C-terminus)
- Clone
- SG4-D1b
- Isotype
- IgG1 kappa
- Top Product
- Discover our top product DRD5 Anticorps primaire
-
-
- Indications d'application
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
- WB : 2 μg/mL - Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Tris-glycine, NaCl 150 mM buffer, Sodium azide 0.05 %
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C/-80 °C
- Stockage commentaire
- Aliquot and store at -20°C or -80°C. Avoid freeze-thaw cycles.
-
- Antigène
- DRD5 (Dopamine Receptor D5 (DRD5))
- Autre désignation
- Dopamine D5 Receptor (DRD5 Produits)
- Synonymes
- anticorps DRD5, anticorps DBDR, anticorps DRD1B, anticorps DRD1L2, anticorps D1B, anticorps D5R, anticorps Drd-5, anticorps Drd1b, anticorps Gpcr1, anticorps dopamine receptor D5, anticorps DRD5, anticorps Drd5
- Pathways
- Regulation of Systemic Arterial Blood Pressure by Hormones, cAMP Metabolic Process, Regulation of long-term Neuronal Synaptic Plasticity
-